Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Cerulean Pharma Inc. Senior Executive to Present at the National Nanotechnology Innovation Summit: Alexandra Glucksmann Invited to Highlight Company’s Progress in Applying Nanotechnology in the Life Sciences

Abstract:
Cerulean Pharma Inc., a leader in designing and developing nanopharmaceuticals, today announced that Alexandra Glucksmann, Ph.D., the Company's Senior Vice President, Research and Business Operations, will present at the Nanotechnology Innovation Summit being organized by the Nano Science and Technology Institute (NSTI) in celebration of the 10th anniversary of the National Nanotechnology Initiative (NNI). The Summit is being held in Washington, D.C., from December 8-10, 2010.

Cerulean Pharma Inc. Senior Executive to Present at the National Nanotechnology Innovation Summit: Alexandra Glucksmann Invited to Highlight Company’s Progress in Applying Nanotechnology in the Life Sciences

Cambridge, MA | Posted on June 3rd, 2013

Dr. Glucksmann has been invited to give an address in the Innovations in Life Science Technologies session of the Summit. In her address, she will highlight Cerulean's advancement of first-in-class nanopharmaceutical drug candidates in pre-clinical and clinical development. Additionally, Dr. Glucksmann will showcase the unique potential of Cerulean's nanopharmaceutical platform to enhance efficacy of therapeutic agents while maintaining high quality of life for patients. Dr. Glucksmann will present at 11:10 a.m. EST on Friday, December 10, 2010 in the Gaylord National Hotel and Convention Center in Washington, D.C.

The Summit is gathering leaders in nanotechnology research and development as well as in policy and finance. Other invited speakers include representatives from the White House, federal government departments and agencies, academic institutes, and industry, who will discuss the latest developments and innovations in nanotechnology. The NNI was established in 2001 with the vision of advancing leadership in nanotechnology through collaborations and dedicated funding.

####

About Cerulean Pharma Inc.
Cerulean Pharma Inc. is a clinical-stage company specializing in the design and development of nanopharmaceuticals optimized to make drugs more effective and with fewer side effects. Cerulean is applying its proprietary nanopharmaceutical platform technologies and specialized capabilities to advance a new class of therapeutic agents for diseases with unmet medical needs. With an initial focus in oncology, the Company’s technology platform can be readily applied to a wide range of drug molecules, ranging from small molecules to peptides and RNAs. Cerulean is privately financed and funded by experienced healthcare investors, including Polaris Venture Partners, Venrock, Lilly Ventures, Lux Capital, Bessemer Venture Partners, Alexandria Real Estate Equities, and William H. Rastetter. Cerulean is located in Cambridge, Massachusetts.

For more information, please click here

Contacts:
Schwartz Communications
Andrew Law/Benjamin Navon
+1 781-684-0770

Copyright © Business Wire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Metal oxide sandwiches: New option to manipulate properties of interfaces February 8th, 2016

Canadian physicists discover new properties of superconductivity February 8th, 2016

Leading bugs to the death chamber: A kinder face of cholesterol February 8th, 2016

From allergens to anodes: Pollen derived battery electrodes February 8th, 2016

Nanomedicine

Leading bugs to the death chamber: A kinder face of cholesterol February 8th, 2016

UTHealth research looks at nanotechnology to help prevent preterm birth February 7th, 2016

Scientists take key step toward custom-made nanoscale chemical factories: Berkeley Lab researchers part of team that creates new function in tiny protein shell structures February 6th, 2016

Hepatitis virus-like particles as potential cancer treatment February 5th, 2016

Announcements

Scientists create laser-activated superconductor February 8th, 2016

Canadian physicists discover new properties of superconductivity February 8th, 2016

Leading bugs to the death chamber: A kinder face of cholesterol February 8th, 2016

From allergens to anodes: Pollen derived battery electrodes February 8th, 2016

Events/Classes

Nanotech Security to Present at the Optical Document Security Conference February 11, 2016 February 4th, 2016

New research uses nanotechnology to prevent preterm birth: March of Dimes honors abstract on prematurity at SMFM Annual Meeting February 2nd, 2016

NBC LEARN DEBUTS SIX-PART VIDEO SERIES, “NANOTECHNOLOGY: SUPER SMALL SCIENCE” Produced by NBC Learn in partnership with the National Science Foundation, and narrated by NBC News/MSNBC’s Kate Snow, series highlights leading research in nanotechnology January 25th, 2016

Leti to Host Workshop on New Photonics Applications During SPIE Photonics West: Researchers also Will Present Four Invited Papers At Feb. 13-18 Conference, 14 Papers, Overall January 25th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic